Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pons

Showing results (391-400 of 437) with videos related to

Pageof 44
Sort By:
Clinical Rheumatology|June 5, 2019
Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohortRocio V Gamboa-Cárdenas, Manuel F Ugarte-Gil, Massardo Loreto, et al.
Annals of the Rheumatic Diseases|May 16, 2024
Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohortMegan R W Barber, Manuel Francisco Ugarte-Gil, John G Hanly, et al.
Annals of the Rheumatic Diseases|October 12, 2023
EULAR recommendations for the management of systemic lupus erythematosus: 2023 updateAntonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, et al.
The Lancet. Rheumatology|May 26, 2025
ERN ReCONNET-SLICC-SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestationsLaurent Arnaud, Guillermo Ruiz-Irastorza, Cynthia Aranow, et al.
Plos Genetics|July 23, 2013
Trans-ancestral studies fine map the SLE-susceptibility locus TNFSF4Harinder Manku, Carl D Langefeld, Sandra G Guerra, et al.
Clinical Rheumatology|August 22, 2019
Correction to: Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohortRocio V Gamboa-Cárdenas, Manuel F Ugarte-Gil, Loreto Massardo, et al.
Annals of the Rheumatic Diseases|July 2, 2011
Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosusElena Sanchez, Ajay Nadig, Bruce C Richardson, et al.
Human Molecular Genetics|October 29, 2013
Allelic heterogeneity in NCF2 associated with systemic lupus erythematosus (SLE) susceptibility across four ethnic populationsXana Kim-Howard, Celi Sun, Julio E Molineros, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 1, 2022
Does the Use of Immunosuppressive Drugs Impact on SARS-CoV-2 Infection Outcome? Data From A National Cohort of Patients With Immune-Mediated Inflammatory Diseases (SAR-COVID Registry)Carolina Ayelen Isnardi, Enrique R Soriano, Cesar Graf, et al.
RMD Open|December 14, 2020
Predictors of renal damage in systemic lupus erythematous patients: data from a multiethnic, multinational Latin American lupus cohort (GLADEL)Cristina Reátegui-Sokolova, Manuel F Ugarte-Gil, Guillermina B Harvey, et al.
Pageof 44

Showing results (391-400 of 437) with videos related to

Sort By:
Pageof 44
Clinical Rheumatology|June 5, 2019
Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohortRocio V Gamboa-Cárdenas, Manuel F Ugarte-Gil, Massardo Loreto, et al.
Annals of the Rheumatic Diseases|May 16, 2024
Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohortMegan R W Barber, Manuel Francisco Ugarte-Gil, John G Hanly, et al.
Annals of the Rheumatic Diseases|October 12, 2023
EULAR recommendations for the management of systemic lupus erythematosus: 2023 updateAntonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, et al.
The Lancet. Rheumatology|May 26, 2025
ERN ReCONNET-SLICC-SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestationsLaurent Arnaud, Guillermo Ruiz-Irastorza, Cynthia Aranow, et al.
Plos Genetics|July 23, 2013
Trans-ancestral studies fine map the SLE-susceptibility locus TNFSF4Harinder Manku, Carl D Langefeld, Sandra G Guerra, et al.
Clinical Rheumatology|August 22, 2019
Correction to: Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohortRocio V Gamboa-Cárdenas, Manuel F Ugarte-Gil, Loreto Massardo, et al.
Annals of the Rheumatic Diseases|July 2, 2011
Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosusElena Sanchez, Ajay Nadig, Bruce C Richardson, et al.
Human Molecular Genetics|October 29, 2013
Allelic heterogeneity in NCF2 associated with systemic lupus erythematosus (SLE) susceptibility across four ethnic populationsXana Kim-Howard, Celi Sun, Julio E Molineros, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 1, 2022
Does the Use of Immunosuppressive Drugs Impact on SARS-CoV-2 Infection Outcome? Data From A National Cohort of Patients With Immune-Mediated Inflammatory Diseases (SAR-COVID Registry)Carolina Ayelen Isnardi, Enrique R Soriano, Cesar Graf, et al.
RMD Open|December 14, 2020
Predictors of renal damage in systemic lupus erythematous patients: data from a multiethnic, multinational Latin American lupus cohort (GLADEL)Cristina Reátegui-Sokolova, Manuel F Ugarte-Gil, Guillermina B Harvey, et al.
Pageof 44